Back to LCT Homepage Targeting Huntington's Disease, Stroke, Type 1 Diabetes and Haemophilia
Living Cell Technologies
LCT - Living Cell Technologies
News updates: Subscribe
Unsubscribe


June 5, 2008
LCT Expands Diabetes Clinical Trial
June 3, 2008
LCT Lists on International OTCQX
May 21, 2008
LCT interviewed by New Zealand TV program, Close Up
May 12, 2008
LCT presents encapsulation technology at conference
May 8, 2008
LCT features on Channel Ten News
May 8, 2008
LCT prepares to list on international OTCQX
 

News

The Living Cell Quarterly Newsletter - February 2007
February 5, 2007

  • Diabetes clinical trial approved
  • Share purchase plan offer opens
  • Outlook for 2007
  • Interview with Dr Paul Tan, Chief Executive Officer
  • Related Document
    Download ( = 142Kb )

    LCT - Living Cell Technologies
    What is xenotransplantation?
    The use of living animal cells, tissues or organs in human therapeutics. >more

    What is DiabeCell?
    DiabeCell is a porcine pancreatic cell product for the treatment of insulin-dependent diabetes. >more

    What is NeurotrophinCell?
    A choroid plexus (brain) cell product with the potential to treat diseases of the nervous system such as Huntington's disease and stroke. >more

    What is LCT's encapsulation technology?
    The living cells are covered in a seaweed-derived coating (alginate encapsulation) to form capsules which eliminate the
    need for toxic immunosuppressant drugs and allow the release of beneficial factors.
    >more
       
    graphic design and website design - PDF Communications Ltd